OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer.
Published in:
Clinical & Translational Oncology, 2014, v. 16, n. 11, p. 942, doi. 10.1007/s12094-014-1212-8
By:
- Sastre, J.;
- Argilés, G.;
- Benavides, M.;
- Feliú, J.;
- García-Alfonso, P.;
- García-Carbonero, R.;
- Grávalos, C.;
- Guillén-Ponce, C.;
- Martínez-Villacampa, M.;
- Pericay, C.
Publication type:
Article
Depicting the evolving scenario of translational-guided drug development.
Published in:
2012
By:
- Argilés, G.;
- Rodon, J.;
- Tabernero, J.
Publication type:
Editorial
Comparison of Prognostic Capacity for Overall Survival (OS) and Disease-Free Survival (DFS) of Neuroendocrine Tumors (NETs) Classifications: 2010 WHO, TNM Staging-ENETS and AJCC.
Published in:
Neuroendocrinology, 2012, v. 96, p. 10
By:
- Mulet-Margalef, N.;
- Landolfi, S.;
- Sánchez-Ollé, G.;
- Argilés, G.;
- Balsells, J.;
- Castro, S.;
- De Torres, I.;
- Torrejón, D.;
- Olsina, J.;
- Capdevila, J.
Publication type:
Article
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.
Published in:
British Journal of Cancer, 2022, v. 126, n. 11, p. 1548, doi. 10.1038/s41416-022-01737-2
By:
- Van Cutsem, E.;
- Danielewicz, I.;
- Saunders, M. P.;
- Pfeiffer, P.;
- Argilés, G.;
- Borg, C.;
- Glynne-Jones, R.;
- Punt, C. J. A.;
- Van de Wouw, A. J.;
- Fedyanin, M.;
- Stroyakovskiy, D.;
- Kroening, H.;
- Garcia-Alfonso, P.;
- Wasan, H.;
- Falcone, A.;
- Fougeray, R.;
- Egorov, A.;
- Amellal, N.;
- Moiseyenko, V.
Publication type:
Article
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.
Published in:
2022
By:
- Van Cutsem, E;
- Danielewicz, I;
- Saunders, M P;
- Pfeiffer, P;
- Argilés, G;
- Borg, C;
- Glynne-Jones, R;
- Punt, C J A;
- Van de Wouw, A J;
- Fedyanin, M;
- Stroyakovskiy, D;
- Kroening, H;
- Garcia-Alfonso, P;
- Wasan, H;
- Falcone, A;
- Fougeray, R;
- Egorov, A;
- Amellal, N;
- Moiseyenko, V
Publication type:
journal article

Found: 5

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer.

Depicting the evolving scenario of translational-guided drug development.

Comparison of Prognostic Capacity for Overall Survival (OS) and Disease-Free Survival (DFS) of Neuroendocrine Tumors (NETs) Classifications: 2010 WHO, TNM Staging-ENETS and AJCC.

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.